The treatment of hydrocephalus is a challenging one. The development of shunt devices have greatly improved the survival and quality of life of paediatric patients with hydrocephalus; however, shunt ...

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...

Nearly all patients (93.6%) reported decreased vision, and 87.2% suffered headaches. The most common issue was shunt obstruction (51%), followed by low tension headaches (63.8%). The peritoneal side ...

Peritoneal washing (abdominopelvic washing) is a procedure used to diagnose whether certain types of cancer are present in the peritoneal cavity—the space between the membranes that line the abdomen.

14 All patients received a ventriculo-peritoneal shunt with an adjustable valve and were evaluated post-surgery at median 8 months (IQR 6:12) by the same clinical protocol. All shunts were working at ...

HOUSTON - I recently had the extraordinary opportunity to step into the operating room at Texas Children's Hospital, where a renowned surgeon invited me to witness a transformative procedure for ...

Patients operated intracranially within the past 6 months, patients with ventriculo-peritoneal shunts, with cSDH in relation to arachnoidal cysts were excluded. The Nordic health care system with ...

The global cerebrospinal fluid management devices market size was valued at USD 1.21 billion in 2024 and is projected to grow from USD 1.27 billion in 2025 to reach USD 1.74 billion by 2033 , ...

Texas-based medical device company Alleviant has received a breakthrough device status from the US Food and Drug Administration (FDA) for its new no-implant atrial shunt for heart failure and will ...

Rehabilitation Medicine Department, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University (The First Hospital of Changsha, Changsha, China Tuberculous meningitis ...